About precision medicine group
Expertise that outpaces the pace of innovation
A seismic shift is occurring throughout the healthcare landscape, as precision medicine replaces the traditional one-size-fits-all approach.
In tandem, around the globe, regulators and payers are demanding increasingly robust evidence, large provider systems are bearing risk, and consumers are shouldering more and more of the cost of care. As these trends escalate, there is mounting pressure to convincingly demonstrate value and validate outcomes. Precision Medicine Group can help you navigate these challenges.
Precision Medicine Group unites three entities—Precision for Medicine, Precision for Value, and precisioneffect—to support our pharmaceutical and life sciences clients through every stage of product development and commercialization.
Precision Medicine Group answers your critical business questions
Precision Medicine Group creates and acquires highly successful science-based service organizations
Our Executive Leadership
Ethan D. Leder, JDCo-founder, Executive Chairman 240.654.0730
Entrepreneur, focused on building and managing innovative, market-leading companies that address critical gaps in the healthcare industry. These include United BioSource Corporation (UBC), acquired by Medco Health Solutions in late 2010; U.S. Bioservices, Inc., acquired by AmerisourceBergen in 2002; and HealthCare Financial Partners, Inc., acquired by GE Capital in late 1999. Ethan holds a JD from Georgetown University and a BA from Johns Hopkins University, where he is on the Board of Trustees.
Mark. P. Clein, MBACo-founder, Chief Executive Officer 240.654.0730
Healthcare industry expert and co-founder of industry-leading ventures—including United BioSource Corporation (UBC), a leader in real-world research addressing safety, value, and comparative effectiveness for the life sciences industry, and US Bioservices, a provider of personalized, direct-to-patient distribution services for specialty pharmaceuticals and biologics. Mark was CEO of PMR Corporation, a leading provider of outpatient services for psychiatric and central nervous system disorders. He holds an MBA from Columbia Graduate School of Business and a BA from the University of North Carolina, where he serves on the Arts and Sciences Foundation.
Chad ClarkCo-President and Chief Operating Officer; President, Precision for Medicine 240.654.0730
Recognized industry leader focused on combining cutting-edge technology, strategic program design and operational excellence to help life sciences companies effectively address the increasing evidence demands and need to accelerate research initiatives. Previous experience spans the execution of phase I-IV clinical trials, specialty lab services, biospecimen logistics and banking, risk management, and patient support initiatives, with knowledge across all major therapeutic areas and a wide range of treatment settings. Chad holds a BS in Biology from the University of North Carolina.
Dan Renick, RPhCo-President and Chief Commercial Officer; President, Precision Value & Health 212.686.2650
Healthcare professional for 20+ years, holding a wealth of information on stakeholders across managed care, pharmaceutical managed markets, pharmacy provider organizations, and market access strategic consulting. Previous roles include President of Hobart Group Holdings, and executive positions at Humana and Merck, providing expert insight into various segments and channels of managed markets. Dan holds a pharmacy degree from the University of Kentucky and a BS in chemistry and biology from Western Kentucky University.